Literature DB >> 16415766

Plasma glucose goals and therapeutic management in elderly diabetic patients.

T Constans1.   

Abstract

In the elderly diabetic patient, therapeutic decision making is not entirely based on evidence acquired from large-scale studies conducted in young adults. In this population autonomy, co-morbidity and prognosis are all objective parameters which must be taken into consideration. Frail patients run the risk of hypoglycaemia if the therapeutic goal is too strict. Frail patients can be distinguished from autonomous patients free of serious co-morbidity using evaluation scales validated for geriatric patients enabling the establishment of appropriate goals for the treatment of diabetes without compromising the patients' quality-of-life.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16415766     DOI: 10.1016/s1262-3636(05)73652-1

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  3 in total

1.  The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus.

Authors:  Sei J Lee; W John Boscardin; Irena Stijacic Cenzer; Elbert S Huang; Kathy Rice-Trumble; Catherine Eng
Journal:  J Am Geriatr Soc       Date:  2011-04-11       Impact factor: 5.562

Review 2.  Key priorities in managing glucose control in older people with diabetes.

Authors:  I Bourdel Marchasson; J Doucet; B Bauduceau; G Berrut; J F Blickle; P Brocker; T Constans; A Fagot Campagna; E Kaloustian; V Lassmann Vague; P Lecomte; D Simon; D Tessier; C Verny; U M Vischer
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

3.  Efficacy and safety of insulin lispro in geriatric patients with type 2 diabetes: a retrospective analysis of seven randomized controlled clinical trials.

Authors:  Bradley H Curtis; Tina M Rees; Kim A Gaskins; Justo Sierra-Johnson; Rong Liu; Honghua H Jiang; John H Holcombe
Journal:  Aging Clin Exp Res       Date:  2014-02       Impact factor: 3.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.